Diagnosis and Treatment of Monogenic Hypertension in Children
Journal Title: Journal of European Internal Medicine Professionals (JEIMP) - Year 2024, Vol 2, Issue 1
Abstract
Hypertension (HT) is a common public health problem that develops due to primary and secondary causes. The prevalence of HT in children and adolescents is 3.6%. In childhood HT, complex and polygenic factors such as genetic, environmental, adaptive, neural, and hormonal mechanisms play a role. Among these factors, genetic factors are estimated to contribute to the development of HT by 30-60%; however, known genetic factors explain only 3% of the cases. Monogenic inherited HT is associated with a mutation in a single gene, with or without the influence of mineralocorticoids, leading to increased sodium reabsorption and intravascular volume expansion. Typically, HT in these patients has an early onset, a family history of HT, is associated with electrolyte imbalance, and shows a clinical course refractory to treatment. In treating monogenic inherited HT, understanding functional genetic mutations enables the utilization of highly effective pharmacogenetic pathways. This knowledge provides the opportunity to tailor treatments specifically to target the primary pathophysiological mechanism of the condition. Sodium-dependent, low renin levels, and monogenic inherited HT treatment are based on a low-sodium diet and block the pathological sodium reabsorption mechanism. Diagnosis can be made through physical examination, blood pressure measurement, and measurement of renin, aldosterone, cortisol, and potassium levels. Monogenic inherited HTs are rare. Early diagnosis ensures blood pressure control early on, reducing the morbidity and mortality associated with HT. Genetic tests are necessary to confirm the diagnosis, make a differential diagnosis, and choose appropriate treatment. Clinical manifestations of monogenic inherited HT in some patients extend beyond HT. Other systemic symptoms may accompany HT or manifest at certain stages of life. This article discusses monogenic inherited HT that manifests in the early stages of life, emphasizing the clinical aspects of HT.
Authors and Affiliations
Faysal Gök Medicana International Ankara Hospital, Department of Pediatric Nephrology and Rheumatology, Ankara, Turkey https://orcid. org/0000-0002-1073-3182 Mehmet Emin Demir Atılım University, School of Medicine, Department of Nephrology, Ankara, Turkey https://orcid. org/0000-0003-2491-4926
Keywords
Related Articles
- EP ID EP751151
- DOI https://doi.org/10.5281/zenodo.10654302
- Views 40
- Downloads 0
Knowledge, Attitudes, and Behaviors of Patients Diagnosed with End-Stage Kidney Disease Registered on the Kidney Transplant Waiting List Regarding Organ Transplantation and Donation
Background: The aim of this study is to determine the knowledge, attitudes, and behaviors of patients diagnosed with end-stage renal disease who are registered on the kidney transplant waiting list regarding organ donati...
Acute Pancreatitis After a Late Period of Metformin Intoxication in a Non-Diabetic Patient
Metformin, an oral antidiabetic drug, is the first-line treatment modality for the treatment of non-insulin-dependent diabetes mellitus. Metformin is more commonly associated with gastrointestinal side effects. Acute pan...
Hepatorenal Syndrome: A Mini Review
Hepatorenal syndrome (HRS) is diagnosed in individuals who have no etiologic factors for the development of renal disease other than chronic decompensated liver disease (DLD). HRS represents the end stage of a series o...
Bilateral Subcapsular Cataract in A Patient with Crohn's Disease Taking Oral Budesonide Therapy: A Case Report
Crohn's disease is a chronic, inflammatory disease of the gastrointestinal tract, which can progress with remission and flares. In order to maintain remission, initially; systemic glucocorticoids such as prednisolone are...
Prognosis and Risks for Renal Transplant Recipients During the COVID-19 Pandemic
Background: We aim to compare potential factors that may affect the prognosis of kidney transplant recipients (KTRs) and hemodialysis patients (HDPs) with the diagnosis of COVID-19. Method: This single-center retrospect...